Diabetic Foot Ulcer Treatment Market Size & Share, by Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-Ischemic Ulcer), Product (Wound-Care Dressings, Wound-Care Devices, Active Therapies), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 4603
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Diabetic Foot Ulcer Treatment Market size was valued at USD 2.26 billion in 2024 and is likely to exceed USD 4.93 billion by the end of 2037, registering over 6.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diabetic foot ulcer treatment is evaluated at USD 2.37 billion.

The growth of the market can be attributed to the increasing number of people suffering from diabetes worldwide. The World Health Organization reports that in 2019, diabetes directly caused 1.5 million deaths, with 48% of deaths caused by diabetes occurring before 70 years of age. According to the American Diabetes Association, approximately 11.3% of the American population, or 37.3 million people, had diabetes in 2019. There are 37.3 million adults with diabetes, 28.7 million of whom are diagnosed, and 8.5 million of whom are undiagnosed.

An ulcer on the bottom of the foot is one of the most common diabetic foot complications. By reducing the pressure, promoting healing, and minimizing the chances of amputation, diabetic foot ulcer treatments are particularly useful for treating diabetic foot ulcers. With the aid of advanced medical technology, the diabetic foot ulcer treatment market strives to provide the best possible services in order to facilitate faster and better wound healing for diabetics. Globally, diabetes is becoming one of the most prevalent diseases. Moreover, the rapid adoption of novel wound care devices, the increase in chronic illnesses, such as diabetes and cancer, have contributed to an increase in diabetic foot ulcers among diabetics, and increased disposable incomes are projected to drive market growth over the forecast period. In July 2022, the Bureau of Economic Analysis reported an increase of USD 37.6 billion in disposable personal income, while personal income was up 0.2%. 


Get more information on this report: Request Free Sample PDF

Diabetic Foot Ulcer Treatment Sector: Growth Drivers and Challenges

Growth Drivers

  • An Increase In Sedentary Lifestyles- According to the Centers For Disease Control And Prevention, approximately 60% of U.S. adults fail to engage in an adequate amount of physical activity. Nearly 25 percent of American adults are completely sedentary. An increasing number of diabetics are being diagnosed as a result of physical inactivity. In times of rapid modernization, the food habits of the people have been adversely affected, which in turn has been combined with a faulty and inactive lifestyle. Ultimately, this results in the onset of diabetes and leads to the formation of diabetic foot ulcers as a result. This factor is anticipated to drive global diabetic foot ulcer treatment market growth over the forecast period.

  • Rise in The Geriatric Population Around The World- The group of elderly are particularly affected by diabetes, as their immunity lowers due to old age, they become the prime age group to be burdened with diabetic foot ulcers.  According to a recent report published by the World Bank, at the end of 2021, there were a total of 747,238,580 people over 60 years of age living around the world, and the number of elderly people is anticipated to rise in the future.

  • Rapidly Growing Number of People Developing Diabetic Foot Ulcers (DFU)- It is estimated that between 9 and 26 million people worldwide suffer from diabetic foot ulcers every year. A diabetic foot ulcer is likely to develop during the lifetime of 16 to 24% of patients with diabetes complications.

  • Increasing Prevalence of Obesity Worldwide- Obesity is one the primary risk factors of diabetic ulcers, obesity defects the tissues that causes insulin resistance and glucose uptake. In the period 2000-2020, obesity prevalence increased by 30.5% to 41.9% in the United States. Ages 20-39 showed an obesity prevalence of 39.8%, 40-59 age groups, 44.3%, and 60+ age groups showed a prevalence of 41.5%.

  • Surge In Number Of People Suffering From Type 2 Diabetes - It is expected that the worldwide prevalence of type 2 diabetes will increase to 70,000 per 100,000 individuals by 2030, reflecting an increase in prevalence across all regions of the world.

Challenges

  • High Cost Associated With Advanced Diabetic Foot Ulcer Treatment-despite of the high prevalence of diabetic patients and diabetic foot ulcers, there are no adequate reimbursement policies for its treatment. Moreover, the devices used for advanced wound care are also expensive, which makes the allover treatment costly.
  • Patient Management Rules and Regulations
  • Unawareness of the Availability of Treatment For Diabetic Foot Ulcers

Diabetic Foot Ulcer Treatment Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

6.3%

Base Year Market Size (2024)

USD 2.26 billion

Forecast Year Market Size (2037)

USD 4.93 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Diabetic Foot Ulcer Treatment Segmentation

Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-Ischemic Ulcer)

The global diabetic foot ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.

End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare)

The global diabetic foot ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and homecare. Amongst these four segments, the hospital segment is expected to garner a significant share. The patient suffering with diabetic ulcers should be taken to hospitals, as ulcers can lead to severe infection and it can increase the risk of amputation. Therefore, to avoid the stage of amputation, the patient should be given immediate care of the hospital for dealing with complicated ulcers. The properly trained staff of the hospital can provide intensive care and the patient can be treated with multiple services present in the hospital.

Our in-depth analysis of the global market includes the following segments:

By Ulcer Type

  • Neuropathic Ulcer
  • Ischemic Ulcer
  • Neuro-Ischemic Ulcer

By Product

  • Wound-Care Dressings
  • Wound-Care Devices
  • Active Therapies
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Diabetic Foot Ulcer Treatment Industry - Regional Synopsis

North American Market Forecast   

The North American diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.

APAC Market Statistics

The Asia Pacific diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The market growth in the region is expected on the account of a rise in the number of patients suffering from diabetes. According to the World Health Organization around 77 million Indians over the age of 18 have type 2 diabetes, and over 25 million are prediabetics More than 50% of people do not know they have diabetes, which can cause serious health problems if not diagnosed timely and not provided with adequate treatment. Moreover, this number of further expected to reach around 135 million by 2045.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Diabetic Foot Ulcer Treatment Landscape

    • UPM
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Orpyx Medical Technologies Inc.
    • PENTAX Medical
    • Smith & Nephew plc
    • Organogenesis Inc. 
    • SIGVARIS GROUP
    • 3M
    • Molnlycke Health Care AB,
    • Hill-Rom Holdings, Inc.
    • ConvaTec Inc. 

In the News

  • Orpyx Medical Technologies Inc. introduced Orpyx SI Sensory integrated with remote patient monitoring Insoles for preventing diabetic foot ulcers. It works by monitoring the temperature, pressure and movement and provide the user with real time audio-visual alarms, that enables them to take quicker decision for their health.

  • March 2022, chances of diabetes foot ulcers re-occur by half.

Author Credits:  Radhika Pawar


  • Report ID: 4603
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetic foot ulcer treatment is evaluated at USD 2.37 billion.

The diabetic foot ulcer treatment market size was valued at USD 2.26 billion in 2024 and is likely to exceed USD 4.93 billion by the end of 2037, registering over 6.3% CAGR during the forecast period i.e., between 2025-2037. An increase in sedentary lifestyles, surge in number of people suffering from type 2 diabetes along with increasing obesity among people will boost the market growth.

North America is projected to hold largest industry share by 2037, attributed to ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer.

The major players in the market include UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.
Diabetic Foot Ulcer Treatment Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample